S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
NASDAQ:AVXL

Anavex Life Sciences - AVXL SEC Filings & 10K Form

$11.37
+0.38 (+3.46%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$10.97
$11.71
50-Day Range
$7.65
$12.05
52-Week Range
$7.13
$15.24
Volume
1.43 million shs
Average Volume
1.30 million shs
Market Capitalization
$887.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.25

Recent Anavex Life Sciences SEC Filings

DateFilerForm TypeView
12/02/2022
7:13 AM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2022
4:03 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
06/29/2022
4:23 PM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2022
4:14 PM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2022
4:08 PM
Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2022
4:10 PM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2022
4:12 PM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
4:08 PM
Anavex Life Sciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/27/2022
7:30 PM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2022
3:30 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2022
3:31 PM
Anavex Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/13/2021
6:19 AM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2021
4:30 PM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:36 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:38 PM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:40 PM
Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:26 PM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:19 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:22 PM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2021
8:48 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2021
8:45 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
8:53 PM
Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/28/2021
3:00 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2021
8:30 PM
Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
7:47 AM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2021
3:29 PM
Anavex Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/09/2021
4:06 PM
Anavex Life Sciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2021
8:31 PM
Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
12:22 PM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
1:22 PM
Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
1:24 PM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
1:26 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
1:28 PM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
1:29 PM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
1:17 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
1:20 PM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
4:27 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/28/2020
4:28 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2020
6:06 AM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2020
10:15 AM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2020
6:02 AM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
3:08 PM
Anavex Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2020
3:32 PM
Anavex Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2020
6:06 AM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2020
3:30 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
4:16 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/13/2019
4:10 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
3:31 PM
Anavex Life Sciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/12/2019
3:58 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
6:27 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2019
3:31 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
3:39 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
5:26 AM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2019
3:31 PM
Anavex Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/12/2018
3:39 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
10/09/2018
3:42 PM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:29 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:30 PM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:31 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:32 PM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:33 PM
Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:27 PM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2018
4:06 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2018
4:23 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
4:16 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2018
11:35 AM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2018
3:31 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2018
2:16 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2018
4:00 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2018
10:01 AM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2018
1:06 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
7:56 AM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2017
3:09 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2017
3:11 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2017
4:14 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
This page (NASDAQ:AVXL) was last updated on 2/3/2023 by MarketBeat.com Staff